Company / Interest Expense
Idexx Laboratories Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$41.6M
FY2023
5-year range
$29.8M / $41.6M
FY2019-FY2023
Trend
+4.3%
vs FY2022
Sector context
#27 of 40
Health Care
What the data says
At $42M, Idexx Laboratories's interest expense ranks #14 of 40 in the Health Care sector. Interest Expense has fluctuated over the past 8 years, ranging from $30M in FY2021 to $42M in FY2023.
Based on SEC 10-K filings.
$42M in FY2023 with a 5-year CAGR of +3.7%.
Increased from $30M to $42M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +7.9%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
#14 of 40 in Health CareTop 32% of 40This company $41.6M Sector average $332.7M
▼
-87.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.7%, indicating consistent growth.
- In FY2023, interest expense increased 4.3% year-over-year.
- Ranks #27 out of 40 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $41.6M | +4.3% |
| FY2022 | $39.9M | +33.7% |
| FY2021 | $29.8M | -10.0% |
| FY2020 | $33.1M | +6.7% |
| FY2019 | $31.1M | -10.6% |
| FY2018 | $34.7M | -6.7% |
| FY2017 | $37.2M | +16.2% |
| FY2016 | $32.0M | +9.6% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026